Prevalence of Autoimmune Disease Among Patients With Lung Cancer: Implications for Immunotherapy Treatment Options

JAMA Oncol. 2016 Nov 1;2(11):1507-1508. doi: 10.1001/jamaoncol.2016.2238.

¹ Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas2Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas.
² Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas3Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas.
³ Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas.

No abstract available

MeSH terms